A Case of Recurrent Acute Pancreatitis Following Ocrelizumab Use

    April 2024 in “ DAHUDER Medical journal ”
    Elif Işıklar, Berivan Akdoğan, Uygar Yavaş, İsmail Demir
    Studysummary This case report presents an instance of acute pancreatitis following the use of ocrelizumab and suggests that its B lymphocyte suppression may contribute to pancreatitis by affecting cytokine release and T lymphocyte regulation.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on dergipark.org.tr →
    Discuss this study in the Community →